Acurx Pharmaceuticals, Inc.
ACXP· Nasdaq
ACXPAcurx Pharmaceuticals, Inc.
Filed Nov 10, 2022 · 10-Q · 41 days after period end · 0001558370-22-017408
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Net Income | -$3.54M | -$4.64M | -$1.31M |
| EPS Diluted | -$0.32 | -$0.46 | -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acurx Pharmaceuticals, Inc. · CIK 1736243 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 10, 2022 · 41 d after period end
